Abiopharma

Smith+Nephew PLC Notification

New Form SCHEDULE 13D/A - GeneDx Holdings Corp. Filed: 2025-08-26 AccNo: 0000919574-25-005136 Size: 33 KB

Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action

SCWorx Expands Healthcare Data Management Network with New Collaboration

New Form 144 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-26 AccNo: 0001959173-25-005533 Size: 5 KB

Westlake annuncia lacquisizione dellattività di soluzioni di compounding di ACI

New Form 25 - COSCIENS Biopharma Inc. Filed: 2025-08-26 AccNo: 0001493152-25-012330 Size: 17 KB

Holloway Jean F 🟡 adjusted position in 10.0K shares (1 derivative) of ARTIVION, INC. (AORT) at $44.37 Transaction Date: Aug 25, 2025 | Filing ID: 000005

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG

Director RICHINS PAUL O 🔴 sold 100 shares of UTAH MEDICAL PRODUCTS INC (UTMD) at $60.34 Transaction Date: Aug 25, 2025 | Filing ID: 000001

New Form 144 - RECURSION PHARMACEUTICALS, INC. Filed: 2025-08-26 AccNo: 0001959173-25-005530 Size: 6 KB

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

Agenus Inc. - Update: Agenus Aug 27 StakeholderWebcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up